Search Page

1

Cite

Share

Clinical evaluation of a new tracheal impedance cardiography method.

van der Kleij SC, Koolen BB, Newhall DA, Gerritse BM, Rosseel PM, Rijpstra TA, Geisler FE, van der Meer NJ. van der Kleij SC, et al. Among authors: koolen bb. Anaesthesia. 2012 Jul;67(7):729-33. doi: 10.1111/j.1365-2044.2012.07089.x. Epub 2012 Mar 15. Anaesthesia. 2012. PMID: 22420758 Free article.

Cite

Share

2

Cite

Share

Molecular Imaging in Breast Cancer: From Whole-Body PET/CT to Dedicated Breast PET.

Koolen BB, Vogel WV, Vrancken Peeters MJ, Loo CE, Rutgers EJ, Valdés Olmos RA. Koolen BB, et al. J Oncol. 2012;2012:438647. doi: 10.1155/2012/438647. Epub 2012 Jul 10. J Oncol. 2012. PMID: 22848217 Free PMC article.

Cite

Share

3

Cite

Share

First clinical experience with a dedicated PET for hanging breast molecular imaging.

Koolen BB, Aukema TS, González Martínez AJ, Vogel WV, Caballero Ontanaya L, Vrancken Peeters MJ, Vroonland CJ, Rutgers EJ, Benlloch Baviera JM, Valdés Olmos RA. Koolen BB, et al. Q J Nucl Med Mol Imaging. 2013 Mar;57(1):92-100. Q J Nucl Med Mol Imaging. 2013. PMID: 23474637

Cite

Share

4

Cite

Share

Association of perioperative troponin and atrial fibrillation after coronary artery bypass grafting.

Koolen BB, Labout JA, Mulder PG, Gerritse BM, Rijpstra TA, Bentala M, Rosseel PM, van der Meer NJ. Koolen BB, et al. Interact Cardiovasc Thorac Surg. 2013 Oct;17(4):608-14. doi: 10.1093/icvts/ivt259. Epub 2013 Jun 20. Interact Cardiovasc Thorac Surg. 2013. PMID: 23788194 Free PMC article.

Cite

Share

5

Cite

Share

PET/CT with ¹⁸F-FDG predicts short-term outcome in stage II/III breast cancer patients upstaged to N2/3 nodal disease.

Teixeira SC, Koolen BB, Elkhuizen PH, Vrancken Peeters MT, Stokkel MP, Rodenhuis S, van der Noort V, Rutgers EJ, Valdés Olmos RA. Teixeira SC, et al. Among authors: koolen bb. Eur J Surg Oncol. 2017 Apr;43(4):625-635. doi: 10.1016/j.ejso.2016.10.012. Epub 2016 Oct 31. Eur J Surg Oncol. 2017. PMID: 27847287

Cite

Share

6

Cite

Share

Accuracy of 18F-FDG PET/CT for primary tumor visualization and staging in T1 breast cancer.

Koolen BB, van der Leij F, Vogel WV, Rutgers EJ, Vrancken Peeters MJ, Elkhuizen PH, Valdés Olmos RA. Koolen BB, et al. Acta Oncol. 2014 Jan;53(1):50-7. doi: 10.3109/0284186X.2013.783714. Epub 2013 May 14. Acta Oncol. 2014. PMID: 23672678

Cite

Share

7

Cite

Share

Additional value of ¹⁸F-FDG PET/CT response evaluation in axillary nodes during neoadjuvant therapy for triple-negative and HER2-positive breast cancer.

van Ramshorst MS, Teixeira SC, Koolen BB, Pengel KE, Gilhuijs KG, Wesseling J, Rodenhuis S, Valdés Olmos RA, Rutgers EJ, Vogel WV, Sonke GS, Vrancken Peeters MT. van Ramshorst MS, et al. Among authors: koolen bb. Cancer Imaging. 2017 May 25;17(1):15. doi: 10.1186/s40644-017-0117-5. Cancer Imaging. 2017. PMID: 28545563 Free PMC article.

Cite

Share

8

Cite

Share

Locoregional lymph node involvement on 18F-FDG PET/CT in breast cancer patients scheduled for neoadjuvant chemotherapy.

Koolen BB, Valdés Olmos RA, Elkhuizen PH, Vogel WV, Vrancken Peeters MJ, Rodenhuis S, Rutgers EJ. Koolen BB, et al. Breast Cancer Res Treat. 2012 Aug;135(1):231-40. doi: 10.1007/s10549-012-2179-1. Epub 2012 Jul 28. Breast Cancer Res Treat. 2012. PMID: 22872522

Cite

Share

9

Cite

Share

Combined PET-CT and axillary lymph node marking with radioactive iodine seeds (MARI procedure) for tailored axillary treatment in node-positive breast cancer after neoadjuvant therapy.

Koolen BB, Donker M, Straver ME, van der Noordaa MEM, Rutgers EJT, Valdés Olmos RA, Vrancken Peeters MJTFD. Koolen BB, et al. Br J Surg. 2017 Aug;104(9):1188-1196. doi: 10.1002/bjs.10555. Epub 2017 May 19. Br J Surg. 2017. PMID: 28524246

Cite

Share

10

Cite

Share

Validation of a web-based version of the asthma control test and childhood asthma control test.

Koolen BB, Pijnenburg MW, Brackel HJ, Landstra AM, van den Berg NJ, Merkus PJ, Hop WC, Vaessen-Verberne AA. Koolen BB, et al. Pediatr Pulmonol. 2011 Oct;46(10):941-8. doi: 10.1002/ppul.21458. Epub 2011 Apr 1. Pediatr Pulmonol. 2011. PMID: 21462363 Clinical Trial.

Cite

Share